Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas

Journal of Neuro-Oncology

Volumn 99, Issue 2, 2010, Pages 209-215

  Antonelli, Manila ^a   Buttarelli, Francesca Romana ^b   Arcella, Antonietta ^c   Nobusawa, Sumihito ^d   Donofrio, Vittoria ^e   Oghaki, Hiroko ^d   Giangaspero, Felice ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c IRCCS NEUROMED   (Italy)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

Author keywords

IDH1 mutation; P53 expression; Pediatric high grade glioma; TP53 mutation; YKL 40 expression

Indexed keywords

PROTEIN IDH1; PROTEIN P53; PROTEIN YKL 40; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CANCER GRADING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MALE; OVERALL SURVIVAL; PRESCHOOL CHILD; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; SCHOOL CHILD;

ADOLESCENT; ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DNA, NEOPLASM; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; INFANT, NEWBORN; ISOCITRATE DEHYDROGENASE; LECTINS; MALE; MUTATION; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 77956056197     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0129-5     Document Type: Article

References (33)

1. P Kaatsch CH Rickert J Kühl J Schüz J Michaelis 2001 Population-based epidemiologic data on brain tumors in German children Cancer. Dec 15 3155 3164 10.1002/1097-0142(20011215)92:12<3155::AID-CNCR10158>3.0. CO;2-C
2. TS Kim AL Halliday ET Hedley-Whyte K Convery 1991 Correlates of survival and the Daumas-Duport grading system for astrocytomas J Neurosurg 74 27 37 10.3171/jns.1991.74.1.0027 1:STN:280:DyaK3M%2FnvF2jtg%3D%3D 1984503
3. Louis DN, Ohgaki H, Wiestler OD, Cavanee WK (eds) (2007) WHO classification of tumours of the central nervous system. IARC, Lyon
4. H Ohgaki P Dessen B Jourde S Horstmann T Nishikawa PL Di Patre C Burkhard D Schüler NM Probst-Hensch PC Maiorka N Baeza P Pisani Y Yonekawa MG Yasargil UM Lütolf P Kleihues 2004 Genetic pathways to glioblastoma: a population-based study Cancer Res 1 6892 6899 10.1158/0008-5472.CAN-04-1337
5. H Ohgaki P Kleihues 2007 Genetic pathways to primary and secondary glioblastoma Am J Pathol 170 1445 1453 10.2353/ajpath.2007.070011 1:CAS:528:DC%2BD2sXlvFCns74%3D 17456751
6. S Nobusawa T Watanabe P Kleihues H Ohgaki 2009 IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas Clin Cancer Res 15 6002 6007 10.1158/1078-0432.CCR-09-0715 1:CAS:528:DC%2BD1MXhtF2ltbbL 19755387
7. IF Pollack SD Finkelstein J Woods J Burnham EJ Holmes RL Hamilton AJ Yates JM Boyett JL Finlay R Sposto 2002 Expression of p53 and prognosis in children with malignant gliomas N Engl J Med 346 420 427 10.1056/NEJMoa012224 1:CAS:528:DC%2BD38XhtVWqu78%3D 11832530
8. BR Rood TJ Macdonald 2005 Pediatric high grade glioma: molecular genetics clues for innovative therapeutic approaches J Neurooncol 75 267 272 10.1007/s11060-005-6749-5 1:CAS:528:DC%2BD28XhtVynsLk%3D 16195804
9. CH Rickert R Sträter P Kaatsch H Wassmann H Jürgens B Dockhorn-Dworniczak W Paulus 2001 Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases Am J Pathol 158 1525 1532 1:STN:280:DC%2BD3M3gvFKnsw%3D%3D 11290570
10. D Faury A Nantel SE Dunn MC Guiot T Haque P Hauser M Garami L Bognár Z Hanzély PP Liberski E Lopez-Aguilar ET Valera LG Tone AS Carret RF Del Maestro M Gleave JL Montes T Pietsch S Albrecht N Jabado 2007 Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors J Clin Oncol 25 1196 1207 10.1200/JCO.2006.07.8626 1:CAS:528:DC%2BD2sXkvFymsrY%3D 17401009
11. T Haque D Faury S Albrecht E Lopez-Aguilar P Hauser M Garami Z Hanzély L Bognár RF Del Maestro J Atkinson A Nantel N Jabado 2007 Gene expression profiling from formalin-fixed paraffin-embedded tumors of pediatric glioblastoma Clin Cancer Res 13 6284 6292 10.1158/1078-0432.CCR-07- 0525 1:CAS:528:DC%2BD2sXht1Cgtb7E 17975139
12. R Johnson KD Wright RJ Gilbertson 2009 Molecular profiling of pediatric brain tumors: insight into biology and treatment Curr Oncol Rep 11 68 72 10.1007/s11912-009-0011-9 1:CAS:528:DC%2BD1MXltVSlu7g%3D 19080744
13. AL Rivera CE Pelloski E Sulman K Aldape 2008 Prognostic and predictive markers in glioma and other neuroepithelial tumors Curr Probl Cancer 32 97 123 10.1016/j.currproblcancer.2008.02.003 18501774
14. CE Pelloski A Mahajan M Maor EL Chang S Woo M Gilbert H Colman H Yang A Ledoux H Blair S Passe RB Jenkins KD Aldape 2005 YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma Clin Cancer Res 1 3326 3334 10.1158/1078-0432.CCR-04-1765
15. JM Cunningham DW Kimmel BW Scheithauer JR O'Fallon PJ Novotny RB Jenkins 1997 Analysis of proliferation markers and p53 expression in gliomas of associated origin: relationship and prognostic value J Neurosurg 86 121 130 10.3171/jns.1997.86.1.0121 1:STN:280:DyaK2s7ktFynsg%3D%3D 8988090
16. RA Danks G Chopra MF Gonzales JM Orian AH Kaye 1995 Aberrant p53 expression does not correlate with the prognosis in anaplastic astrocytoma Neurosurgery 37 246 254 10.1227/00006123-199508000-00009 1:STN:280: DyaK28%2Fmsl2gsw%3D%3D 7477776
17. H Yan DW Parsons G Jin R McLendon BA Rasheed W Yuan I Kos I Batinic-Haberle S Jones GJ Riggins H Friedman A Friedman D Reardon J Herndon KW Kinzler VE Velculescu B Vogelstein DD Bigner 2009 IDH1 and IDH2 mutations in gliomas N Engl J Med 360 765 773 10.1056/NEJMoa0808710 1:CAS:528: DC%2BD1MXitFWru7o%3D 19228619
18. E De Carli X Wang Puget 2009 IDH1 and IDH2 mutations in glioma N Engl J Med 360 2248 2249 10.1056/NEJMc090593 19458374
19. AD Recklies C White H Ling 2002 The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways Biochem J 1 119 126 10.1042/BJ20020075
20. CE Pelloski E Lin L Zhang WK Yung H Colman JL Liu SY Woo AB Heimberger D Suki M Prados S Chang FG Barker 3rd GN Fuller KD Aldape 2006 Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma Clin Cancer Res 1 3935 3941 10.1158/1078-0432.CCR-05-2202
21. KM Malinda L Ponce HK Kleinman LM Shackelton AJ Millis 1999 Gp38 k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells Exp Cell Res 250 168 173 10.1006/excr.1999.4511 1:CAS:528:DyaK1MXktV2ktro%3D 10388530
22. HS Phillips S Kharbanda R Chen WF Forrest RH Soriano TD Wu A Misra JM Nigro H Colman L Soroceanu PM Williams Z Modrusan BG Feuerstein K Aldape 2006 Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis Cancer Cell 9 157 173 10.1016/j.ccr.2006.02.019 1:CAS:528:DC%2BD28XivFWjtL4%3D 16530701
23. S Pfister O Witt 2009 Pediatric gliomas Recent Results Cancer Res 171 67 81 10.1007/978-3-540-31206-2-4 19322538
24. IF Pollack SD Finkelstein J Burnham EJ Holmes RL Hamilton AJ Yates JL Finlay R Sposto 2001 Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort Cancer Res 15 7404 7407
25. Y Cheng HK Ng SF Zhang M Ding JC Pang J Zheng WS Poon 1999 Genetic alterations in pediatric high-grade astrocytomas Hum Pathol 30 1284 1290 10.1016/S0046-8177(99)90057-6 1:CAS:528:DyaK1MXnvVGntbY%3D 10571506
26. V Suri P Das A Jain MC Sharma SA Borkar A Suri D Gupta C Sarkar 2009 Pediatric glioblastomas: a histopathological and molecular genetic study Neuro Oncol 11 274 280 10.1215/15228517-2008-092 18981259
27. Y Okamoto PL Di Patre C Burkhard S Horstmann B Jourde M Fahey D Schüler NM Probst-Hensch MG Yasargil Y Yonekawa UM Lütolf P Kleihues H Ohgaki 2004 Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas Acta Neuropathol 108 49 56 10.1007/s00401-004-0861-z 15118874
28. DW Parsons S Jones X Zhang JC Lin RJ Leary P Angenendt P Mankoo H Carter IM Siu GL Gallia A Olivi R McLendon BA Rasheed S Keir T Nikolskaya Y Nikolsky DA Busam H Tekleab LA Diaz Jr J Hartigan DR Smith RL Strausberg SK Marie SM Shinjo H Yan GJ Riggins DD Bigner R Karchin N Papadopoulos G Parmigiani B Vogelstein VE Velculescu KW Kinzler 2008 An integrated genomic analysis of human glioblastoma multiforme Science 26 321 1807 1812 10.1126/science.1164382
29. J Balss J Meyer W Mueller A Korshunov C Hartmann A von Deimling 2008 Analysis of the IDH1 codon 132 mutation in brain tumors Acta Neuropathol 116 597 602 10.1007/s00401-008-0455-2 1:CAS:528:DC%2BD1cXhtlyhsbfN 18985363
30. Ichimura K, Pearson DM, Kocialkowski S, Bäcklund LM, Chan R, Jones DT, Collins VP (2009) IDH1 mutations are present in the majority of common adult gliomas but are rare in primary glioblastomas. Neuro Oncol (Epub ahead of print)
31. Sanson M, Marie Y, Paris S, Idbaih A, Laffaire J, Ducray F, Hallani SE, Boisselier B, Mokhtari K, Hoang-Xuan K, Delattre JY (2009) Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol (Epub ahead of print)
32. RP Sanders M Kocak PC Burger TE Merchant A Gajjar A Broniscer 2007 High-grade astrocytoma in very young children Pediatr Blood Cancer 49 888 893 10.1002/pbc.21272 17554787
33. JE Wolff AK Gnekow RD Kortmann T Pietsch C Urban N Graf J Kühl 2002 Preradiation chemotherapy for pediatric patients with high-grade glioma Cancer 94 264 271 10.1002/cncr.10114 1:CAS:528:DC%2BD38XlslKntw%3D%3D 11815986 2002